Blood Typing and Crossmatching
Blood typing and crossmatching are essential processes that ensure safe transfusion of blood and blood products. Because red blood cells contain surface antigens that determine blood type, incompatible transfusions can trigger life-threatening immune reactions. Surface antigens are specific molecules embedded in the membrane of blood cells that act as biological identifiers. They signal to the immune system that the cell is “self” or “non-self” and determine blood group compatibility by triggering immune recognition if foreign antigens are present.
What You Need to Know
The ABO blood group is determined by the presence or absence of A and B antigens (proteins, glycoproteins, or glycolipids, depending on the blood group system) on the surface of red blood cells. The blood group system in this article is the ABO system, as it is the most commonly used in transfusion practice. Blood is grouped by either the presence or absence of antigens on erythrocytes:
Type A blood has A antigens and anti-B antibodies.
Type B has B antigens and anti-A antibodies.
Type AB has both antigens and no antibodies — making it the universal recipient.
Type O has no antigens and both antibodies — making it the universal donor for red cells.
The Rh factor refers to the presence (Rh-positive) or absence (Rh-negative) of the D antigen. Rh-negative individuals can develop anti-D antibodies if exposed to Rh-positive blood, which is critical in pregnancy because maternal–foetal incompatibility may cause haemolytic disease of the newborn.
Red blood cell transfusion compatibility:
O⁻ → can give to everyone (universal donor)
O⁺ → can give to all positive blood groups
A → can receive A and O
B → can receive B and O
AB → can receive A, B, AB, and O (universal recipient)
Rh⁻ patients → should receive Rh⁻ blood only
Rh⁺ patients → can receive Rh⁺ or Rh⁻ blood
How to Remember:
Letters match, antibodies attack:
Type A → has A antigen, makes anti-B
Type B → has B antigen, makes anti-A
Type AB → has A and B antigens, makes no ABO antibodies
Type O → has no antigens, makes anti-A and anti-B and anti-AB antibodies
Beyond the Basics
Blood typing and crossmatching are safety processes informed by predictable immunological principles. Their purpose is to ensure that transfused blood cells are recognised as compatible by the recipient’s immune system and are not immediately targeted as foreign. Understanding how this works requires an appreciation of red blood cell antigens and naturally occurring antibodies.
Red Blood Cell Antigens and Blood Groups
Red blood cells express specific surface molecules known as antigens. In the ABO system, these antigens are carbohydrate structures embedded in the red cell membrane. Individuals inherit genes that determine whether they express A antigens, B antigens, both, or neither. This results in the four major blood groups: A, B, AB, and O.
The immune system develops tolerance to self-antigens early in life. As a result, a person does not produce antibodies against the antigens present on their own red cells. However, they do produce antibodies against ABO antigens they lack. For example, a person with group A blood does not recognise B antigens as self and therefore has circulating anti-B antibodies. These antibodies are present without prior transfusion or exposure and are capable of reacting immediately if incompatible blood is introduced.
The Rh System and Immune Sensitisation
The Rh system, most importantly the RhD immunoglobulin (anti-D antigen), differs from the ABO system in that antibodies are not naturally present. Individuals who lack the D antigen are Rh-negative and do not automatically have anti-D antibodies. Antibody formation occurs only after exposure to Rh-positive red cells, such as through transfusion or pregnancy.
Once sensitisation occurs, the immune system retains memory. Subsequent exposure to Rh-positive blood can provoke a rapid antibody response. This is why Rh compatibility is particularly important in transfusion practice and obstetric care, and why antibody screening is required even when ABO groups appear compatible.
Blood Typing: What Is Being Tested
Blood typing identifies which antigens are present on a patient’s red blood cells and which antibodies are present in their plasma. This is done through forward typing (cell grouping), which tests patient red cells against known antibodies, and reverse typing, which tests patient plasma against known red cells. The results must align logically; the antigens present on red cells must match the absence of corresponding antibodies in plasma. This dual testing approach reduces error and ensures internal consistency before blood is selected.
Antibody Screening and Why It Matters
Beyond ABO and Rh, red blood cells carry many other antigens. Some patients develop antibodies to these minor antigens following previous transfusions or pregnancies. These antibodies may not cause immediate symptoms but can still react with donor red cells.
Antibody screening tests the patient’s plasma against cells carrying common clinically significant antigens. A positive screen signals that additional testing is required to identify the specific antibody and locate compatible donor units that lack the corresponding antigen.
Crossmatching: The Final Compatibility Check
Crossmatching is the final safety step before transfusion. It directly tests whether the patient’s plasma reacts with the donor’s red cells. This process simulates what would happen inside the patient’s circulation by mixing the two components under controlled conditions.
If no reaction occurs, the unit is considered compatible. If agglutination or other evidence of immune interaction is detected, the blood must not be transfused. Crossmatching therefore acts as a real-world confirmation that all known antibodies have been accounted for and that the selected blood is safe to administer.
Why Compatibility Is Critical
Blood transfusion introduces living cells into another person’s circulation. If those cells carry antigens recognised as foreign, the immune system responds immediately. Because red blood cells circulate systemically and are present in large numbers, incompatibility has widespread consequences. This is why even small errors in typing, labelling, or patient identification can have catastrophic outcomes.
Compatibility is not simply about matching labels but about aligning immunological identity.
Clinical Connections
In clinical practice, crossmatching involves mixing donor and recipient blood in the laboratory to check for compatibility before transfusing the blood. Transfusion safety relies heavily on nursing vigilance. Correct patient identification, careful preparation, and close monitoring during the first 15 minutes of transfusion are essential (this is when transfusion reactions are most likely to occur). Any symptoms such as fever, flank pain, dyspnoea, itching, hypotension, or anxiety may indicate an adverse reaction.
If a reaction does occur, standard practice is generally to:
Immediately stop the transfusion and disconnect the IV line from the patient (do not discard the blood product or it’s packaging, it can be returned to the blood bank for further testing)
Assess the patient following ABC (airway, breathing, circulation) and continue to monitor vital signs
Maintain IV access, disconnect the blood giving set and attach a new giving set primed with normal saline
Recheck the blood product and patient ID, verifying compatibility and correct blood was administered
Immediately notify the treating doctor and escalate care appropriately
Follow procedure, including additional monitoring, according to local protocol
Rh incompatibility in pregnancy can cause haemolysis of foetal red cells, leading to jaundice, anaemia, or hydrops fetalis. Anti-D prophylaxis prevents sensitisation in Rh-negative mothers. During pregnancy, Rh status is generally checked at the first antinatal visit. A blood test is taken to check:
Blood group (ABO)
Rh(D) status (positive or negative)
Antibody screen (indirect Coombs test)
If the mother is Rh positive, no further Rh-specific monitoring is needed and routine care continues. If the mother is Rh negative, there will be a repeat antibody screening test at around 28 weeks gestation, sometimes later depending on pregnancy risk and local policy. This checks if sensitisation has occurred during pregnancy.
Understanding blood typing also helps interpret pathology results after transfusion, especially when haemoglobin does not rise as expected or when delayed haemolytic reactions occur.
Concept Check
What determines the ABO blood type of an individual?
Why is type O considered the universal donor?
What is the importance of Rh typing in pregnancy?
What symptoms suggest an acute haemolytic transfusion reaction?
How does crossmatching prevent incompatibility?